Humana (HUM) PT Raised to $330 at Argus

Argus raised its price target on Humana (NYSE: HUM) to $330.00 (from $270.00) while maintaining a Buy rating.

Analyst David Toung has a positive view on reports of an acquisition by Wal-Mart (NYSE: WMT). The analyst comments "We think such a merger would provide Humana with substantial benefits, as it could leverage the large customer base at Wal-Mart’s 5,300 U.S. retail locations to expand membership in its Medicare Advantage and other health plans. Humana could also use Wal-Mart stores to expand its network of care delivery clinics."

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• LG Electronics India (LGEL:IN) PT Raised to INR1,815 at ICICI Securities
• AI/ML Innovations plans $2M private placement on the CSE